Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bridge or Continue Coumadin for Device Surgery Randomized Controlled Trial (BRUISE CONTROL)

NCT00800137 is registered in ClinicalTrials.gov with Ottawa Heart Institute Research Corporation as lead sponsor.

NCT NCT00800137
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00800137 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bridge or Continue Coumadin for Device Surgery Randomized Controlled Trial (BRUISE CONTROL)
Lead sponsor
Ottawa Heart Institute Research Corporation
Phase
Phase 4
Overall status
Terminated
Start date
December 31, 2008
Completion date
March 31, 2013
Enrollment
984 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

hematoma